All Posts: News Release
-
Georgetown Researchers Launch ‘Nari Paila,’ Mobile Games to Share Information on Fertility Awareness, Family Planning in Nepal
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 24, 2019) — This month, Georgetown researchers launched a series of mobile games in Nepal to reach young people with information about fertility awareness and family planning. The mobile games, called “Nari Paila” (“Women First”), were developed in collaboration with Gaming Revolution for Inspiring Development (GRID). The games integrate information […]
Category: News Release
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 18, 2019) — The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease. “Atezolizumab, […]
Category: News Release
-
Fertility App ‘Dot’ Found to be As Effective Other Family Planning Methods
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 18, 2019) — Results of a first-of-its-kind prospective study with a family planning app find it to be as effective as other modern methods for avoiding an unplanned pregnancy. Researchers from the Institute for Reproductive Health (IRH) at Georgetown University Medical Center studied women’s use of the Dot app over […]
Category: News Release
-
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 12, 2019) — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms […]
Category: News Release
-
Large Study Reveals Long-Term Outcomes for Prostate Cancer Patients Treated with High Dose, Short Term Radiation
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (February 8, 2019) — A large national study examining a radiation treatment for prostate cancer — popular because it delivers a high dose of therapy in a very short time frame — supports its routine use. The study, conducted at cancer centers around the country including at Georgetown Lombardi Comprehensive Cancer Center, looks at long-term […]
Category: News Release
-
Study Finds HIV+ Cancer Patients Benefit From Immunotherapy
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (February 7, 2019) — The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center. Their study, published in JAMA Oncology, focused on whether a relatively new class of drugs called checkpoint inhibitors is both safe and […]
Category: News Release
-
Perceptions of Chronic Fatigue Syndrome in the Emergency Department
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (January 10, 2019) — Findings from a novel online questionnaire of people with chronic fatigue syndrome (CFS) who rated their perceptions of care in a hospital’s emergency department suggest the majority of these patients do not receive proper care, say researchers from Georgetown University Medical Center. The study, published in the journal Open […]
Category: News Release
-
Georgetown Genetic Counselor Offers Insight on Direct-to-Consumer DNA Testing Kits
WASHINGTON (December 20, 2018) — You better watch out, you better not cry, better not pout, I’m telling you why, DNA tests are coming to town. The DNA testing kit has become a popular holiday gift, with 100 million people expected to have used a direct-to-consumer (DTC) DNA test by the year 2020. However, “you better […]
Category: News Release
-
WHO Expert Panel on Human Gene Editing a ‘Very Good Step,’ says Georgetown Medical Ethicist
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (December 14, 2018) — Today, the World Health Organization (WHO) announced that it is establishing a “global multi-disciplinary expert panel to examine the scientific, ethical, social and legal challenges associated with human gene editing.” The announcement follows a Chinese scientist’s claim that he performed genetic editing to create twin girls who are resistant to HIV […]
Category: News Release
-
Georgetown Lombardi’s Louis M. Weiner, MD, Named a National Academy of Inventors Fellow
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (December 11, 2018) — The National Academy of Inventors (NAI) has named Louis M. Weiner, MD, director of Georgetown Lombardi Comprehensive Cancer Center, to its 2018 class of fellows. According to the NAI, election to NAI Fellow status is the “highest professional distinction accorded to academic inventors who have demonstrated a prolific spirit […]
Category: News Release